Last reviewed · How we verify
NCT06249074
Gluten-free Diet in Women With Autoimmune Thyroiditis
NA trial testing Gluten-free diet in Autoimmune Thyroiditis in 31 participants. Completed in 30 November 2021.
16 November 2021
Quick facts
| Lead sponsor | Medical University of Gdansk |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 31 |
| Start date | 22 September 2020 |
| Primary completion | 16 November 2021 |
| Estimated completion | 30 November 2021 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Gluten-free diet
- Gluten capsules supplementation
- Placebo capsules supplementation
Conditions studied
- Autoimmune Thyroiditis — all drugs for Autoimmune Thyroiditis →
Sponsor
Medical University of Gdansk
Who can join
Adults 20 to 50, female only, with Autoimmune Thyroiditis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this interventional study was to check if the elimination of gluten from the diet of women with autoimmune thyroiditis affects their health and thyroid function, quality of life, and the gut microbiome composition. The main questions it aimed to answer were: * Does the gluten-free diet worsen the gut microbiome composition? * Does the gluten-free diet improve thyroid function, measured as thyroid stimulating hormone (TSH), thyroid hormones thyroxine (FT4) and triiodothyronine (FT3), thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb)? * Does the gluten-free diet improve the quality of life? Participants: * followed normocaloric gluten-free diet for 8 weeks * after first 4 weeks were randomly assigned to one of two groups. One group over next 4 weeks additionally to gluten-free diet received gluten in gastrosoluble capsules and second group - rice starch (placebo). Blood and stool samples were collected before diet (T0), after 4 weeks (T1) and after 8 weeks of diet (T2) (total of 3 samples per participant). Also each participant completed the ThyPROpl quality of life assessment questionnaire for patients with thyroid diseases in three time points: before the diet (T0), after 4 weeks (T1) and after 8 weeks of the diet (T2).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Gluten-Free Diet Alters the Gut Microbiome in Women with Autoimmune Thyroiditis.
Rodziewicz A, Szewczyk A, Bryl E. · · 2024 · cited 5× · PMID 38474814 · DOI 10.3390/nu16050685 -
Effects of Gluten-Free Diet in Non-Celiac Hashimoto's Thyroiditis: A Systematic Review and Meta-Analysis.
Araújo EMQ, Coutinho-Lima CRO, Sousa AS, Souza LMS, et al · · 2025 · cited 1× · PMID 41228508 · DOI 10.3390/nu17213437
Verify or expand the search:
- PubMed search for NCT06249074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gluten-free diet
Trials testing the same drug.
- NCT06206616 — Liver Steatosis in Pediatric CD Patients · not yet recruiting
- NCT06026449 — Gluten-free Diet in PSC and IBD · NA · active not recruiting
- NCT03451955 — The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS · NA · completed
- NCT03089632 — The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia Symptoms · NA · unknown
- NCT04006886 — Gluten-free Diet in Patients With Primary Sclerosing Cholangitis (PSC) · NA · completed
Other Medical University of Gdansk trials
Trials by the same sponsor.
- NCT07521280 — State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain · NA · not yet recruiting
- NCT07446517 — Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes · NA · recruiting
- NCT07449585 — Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
- NCT07397208 — Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Criticall · not yet recruiting
- NCT07345403 — GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Ana · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06249074 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Gdansk
- Last refreshed: 8 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06249074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing